[Current therapeutics in leprosy: resistance--therapeutic regimens--control strategy].
D002991:Clofazimine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003622:Dapsone / Q000494:pharmacology / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D007918:Leprosy / Q000188:drug therapy* / Q000517:prevention & control; D009166:Mycobacterium leprae / Q000187:drug effects; D013424:Sulfanilamides / Q000627:therapeutic use
D013424:Sulfanilamides; C017265:disulfanilamide; D003622:Dapsone; D002991:Clofazimine
La nouvelle thérapeutique de la lèpre: la résistance--les schémas thérapeutiques--la stratégie de la lutte.